Profil
Mark Chadwick worked as a European Patent Attorney at J.A.
Kemp LLP.
He then worked as a Patent Counsel at Amsterdam Molecular Therapeutics (AMT) Holding NV from 2008 to 2013.
Chadwick received his undergraduate degree from the University of Cambridge and his doctorate from the University of East Anglia.
Ehemalige bekannte Positionen von Mark Chadwick
Unternehmen | Position | Ende |
---|---|---|
Amsterdam Molecular Therapeutics (AMT) Holding NV
Amsterdam Molecular Therapeutics (AMT) Holding NV Miscellaneous Commercial ServicesCommercial Services Amsterdam Molecular Therapeutics (AMT) Holding NV engages in the development of human gene based therapies. The company has a product pipeline of several gene therapy products in development for hemophilia B, acute intermittent porphyria, Parkinson's disease and SanfilippoB. It is expected to be finally dissolved in September 2012. Amsterdam Molecular Therapeutics (AMT) Holding was founded by Sander J. H. van Deventer and John J. P. Kastelein on March 20, 1998 and is headquartered in Amsterdam, Netherlands. | General Counsel | 11.03.2013 |
J.A. Kemp LLP
J.A. Kemp LLP Miscellaneous Commercial ServicesCommercial Services J.A. Kemp & Co. provides protection for patents, trade marks and intellectual property, under International, European and UK law. The company also provides legal advice in the areas of biotechnology, chemistry, electronics and engineering, patent assignments and trade marks. It has offices in the United Kingdom and Germany. The company is headquartered in London, UK. | General Counsel | - |
Ausbildung von Mark Chadwick
University of Cambridge | Undergraduate Degree |
University of East Anglia | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
Amsterdam Molecular Therapeutics (AMT) Holding NV
Amsterdam Molecular Therapeutics (AMT) Holding NV Miscellaneous Commercial ServicesCommercial Services Amsterdam Molecular Therapeutics (AMT) Holding NV engages in the development of human gene based therapies. The company has a product pipeline of several gene therapy products in development for hemophilia B, acute intermittent porphyria, Parkinson's disease and SanfilippoB. It is expected to be finally dissolved in September 2012. Amsterdam Molecular Therapeutics (AMT) Holding was founded by Sander J. H. van Deventer and John J. P. Kastelein on March 20, 1998 and is headquartered in Amsterdam, Netherlands. | Commercial Services |
J.A. Kemp LLP
J.A. Kemp LLP Miscellaneous Commercial ServicesCommercial Services J.A. Kemp & Co. provides protection for patents, trade marks and intellectual property, under International, European and UK law. The company also provides legal advice in the areas of biotechnology, chemistry, electronics and engineering, patent assignments and trade marks. It has offices in the United Kingdom and Germany. The company is headquartered in London, UK. | Commercial Services |